Plants of the Brassicaceae family are well-known for containing the glucosinolate myrosinase system, which is able to release isothiocyanates after plant biotic and abiotic lesions. Erucin (ERU; 1-isothiocyanato-4-(methylthio)-butane), an isothiocyanate particularly abundant in arugula (Eruca sativa Mill., Eruca vesicaria L., etc.), derives from the hydrolysis of the glucosinolate glucoerucin by the enzyme myrosinase. Many other natural isothiocyanates influence cancer cells and, in particular, induce antiproliferative effects at relatively high concentrations. Similar antiproliferative effects have also been shown by the newly emerging gasotransmitter hydrogen sulfide (H 2 S) and by H 2 S-releasing compounds. In a previous study, our group demonstrated that isothiocyanates release H 2 S in biological environments. In this work, we demonstrated the H 2 S-donor properties of ERU in pancreatic adenocarcinoma cells (AsPC-1) and delineated its profile as a chemopreventive or anticancer agent. Indeed, ERU showed significant antiproliferative effects: ERU inhibited AsPC-1 cell viability at relatively high concentrations (30-100 μM). Moreover, ERU inhibited cell migration, altered the AsPC-1 cell cycle, and exhibited proapoptotic effects. Finally, ERU inhibited ERK1/2 phosphorylation. This mechanism is particularly important in AsPC-1 cells because they are characterized by a mutation in KRAS that determines KRAS hyperactivation followed by MAP-kinase hyperphosphorylation, which plays a pivotal role in pancreatic cancer proliferation, growth, and survival.
| INTRODUCTION
In recent years, the anticancer properties of dietary agents have been widely investigated, and in particular, it has been demonstrated that the consumption of Brassicaceae vegetables (crucifers), such as broccoli, cauliflower, cabbage, and rocket salad, is associated with a lower risk of cancer (Fofaria, Ranjan, Kim, & Srivastava, 2015) .
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In fact, some natural ITCs, such as sulforaphane (SFN), phenethyl isothiocyanate, benzyl isothiocyanate (BITC), and erucin (ERU) derive from Brassicaceae plants and have inhibitory effects on the growth of several types of cultured cancer cells, including leukaemia, prostate cancer, breast cancer, lung cancer, cervical cancer, and colorectal cancer. Moreover, ITCs are well absorbed and highly bioavailable, making them promising compounds for anticancer therapies (Fofaria et al., 2015) .
Many studies have demonstrated that ITCs exert anticancer effects through different mechanisms of action, including promoting cell cycle arrest and apoptosis, interacting with the Keap1-Nrf2-ARE pathway and upregulating phase II detoxification enzymes (Fuentes, Paredes-Gonzalez, & Kong, 2015) .
SFN is the most studied isothiocyanate in Brassicaceae vegetables and has been particularly studied in broccoli and broccoli sprouts (Clarke et al., 2011) . However, ERU, an isothiocyanate structurally related to SFN and typically present in high amounts in wild rocket (Eruca sativa Mill.), is still less studied. ERU is produced from its precursor, the glucosinolate glucoerucin, by the plant enzyme myrosinase; a myrosinase-like thioglucosidase activity has been recognized in the bacteria of the human gut. Notably, ERU is also produced in the human body after the biotransformation of SFN through the reduction of the sulfur atom (Melchini & Traka, 2010) . Recently, our group described some synthetic aryl isothiocyanates as H 2 S-donor agents, exhibiting significant effects on the cardiovascular system, attributable to the donation of H 2 S .
Aside from these synthetic compounds, other natural ITCs, such as allyl isothiocyanate, which is highly present in black mustard (Brassica nigra L.), 4-hydroxybenzyl isothiocyanate, which is highly present in white mustard (Sinapis alba L.), benzyl isothiocyanate, which is highly present in garden cress (Lepidium sativum L.), SFN, and ERU have also been described as slow H 2 S-releasing compounds Lucarini et al., 2018) .
H 2 S is a well-known endogenous gasotransmitter that plays pivotal roles in the cardiovascular system and respiratory system and in regulating cell growth. Recent studies have indicated that H 2 S has two opposite effects on cancer cell growth that may be due to the concentration of H 2 S and the time of exposure to cancer cells. This behaviour, defined as "hormetic," has been confirmed in different studies reporting that endogenous H 2 S, as well as the exposure to low levels of exogenous H 2 S or H 2 S-donors for a short duration, could have antiapoptotic effects in cancer cells, promoting and maintaining cancer growth (Hellmich, Coletta, Chao, & Szabo, 2015) . In contrast, treatment with a relatively high concentration of H 2 S-donors for a long time has been reported to inhibit cancer cell growth in different types of tumours, thus indicating that slow-releasing H 2 S donors could be an innovative and promising therapeutic strategy in antineoplastic therapy (Calderone, Martelli, Testai, Citi, & Breschi, 2016 Among the several types of cancer, pancreatic adenocarcinoma is one of the most lethal forms, and although substantial progress has been made in understanding the biology of this cancer, it still has an extremely poor prognosis.
For this reason, in this paper, the AsPC-1 human pancreatic adenocarcinoma cell line was selected. AsPC-1 cells are particularly aggressive due to their molecular and genetic status; in fact, they are characterized by the lack of the LKB1 tumour suppressor protein causing a particular resistance to apoptosis and by homozygote mutations in the KRAS gene, promoting the constitutive activation of this kinase (Deer et al., 2010) . On this basis, in this study, we focused our attention on the anticancer effects of ERU, a natural isothiocyanate with H 2 S donor properties, to investigate the following primary endpoints: its ability to enter AsPC-1 cells and to release H 2 S at the intracellular level, its capacity to inhibit cell viability and migration, its ability to alter the AsPC-1 basal cell cycle, and its ability to exert proapoptotic effects. Finally, a possible mechanism of action was investigated to evaluate the involvement of the MAPK/ERK pathway in the anticancer properties of ERU.
| MATERIALS AND METHODS

| Isolation of natural ERU
Erucin was produced from natural glucoerucin by myrosinase-catalysed hydrolysis. The glucosinolate was purified from E. sativa Mill. seeds stored in the Brassicaceae collection at CREA-CI, Bologna, Italy (Lazzeri et al., 2013) . Glucoerucin was isolated as K + salts from defatted seed meal via extraction with boiling 70% ethanol followed by ion exchange chromatography and gel filtration chromatography, as described previously (Franco et al., 2016) . Isolated glucoerucin was analysed by HPLC-UV after enzymatic desulfation according to the ISO 9167-1 method, yielding 99% purity based on the peak area value and 96% purity based on weight. Myrosinase, 36 U/ml, was isolated from ripe seeds of white mustard (S. alba L.) as previously reported (Pessina, Thomas, Palmieri, & Luisi, 1990 ) and stored at 4°C in sterile distilled water until use. One myrosinase unit (U) is defined as the amount of enzyme that can hydrolyse 1 μmol sinigrin per min at a pH of 6.5 at 37°C. A total of 500 mg of glucoerucin was hydrolysed in the presence of 25 U of myrosinase in 0.1 M potassium phosphate buffer, pH 6.5, for 2 hr at 37°C. ERU was extracted three times with 50 ml dichloromethane using a 250 ml separating funnel. The collected organic phases were unified and concentrated at 37°C by a rotary evaporator under vacuum. The obtained solution was dried using anhydrous Na 2 SO 4 and filtered, and the remaining dichloromethane was evaporated under a weak current of nitrogen. ERU was finally identified by GC-MS analysis on a Bruker The oven temperature was set at 60°C and maintained for 4 min. Then, the temperature was programmed to rise from 60°C to 220°C at a rate of 10°C min −1 and was finally held at 220°C for 4 min. The transfer line was maintained at 280°C, and the ion source was maintained at 220°C.
Split injection (1:20) was applied, and the carrier gas flow (helium) was set at 1 ml min −1 . The mass spectrometer was operated in electron impact mode at 70 eV, scanning the range of 10-250 m/z, in a full scan acquisition mode. Mass spectra were identified by matching the recorded mass spectra with the NIST/EPA/NIH Mass Spectral
Database (NIST 11, Gaithersburg, Maryland 
| Cell culture and cell viability assay
The human pancreas adenocarcinoma ascites metastasis cell line
AsPC-1 (Sigma-Aldrich, passage number 3, population doubling time 38-40 hr) was cultured in RPMI 1640 (Sigma-Aldrich) supplemented with 2 mM glutamine (Sigma-Aldrich), 1 mM sodium pyruvate (SigmaAldrich), 10% foetal bovine serum (Sigma-Aldrich), and 1% of 100 units/ml penicillin and 100 mg/ml streptomycin (Sigma-Aldrich) in tissue culture flasks at 37°C in a humidified atmosphere and 5% CO 2 .
AsPC-1 cells were seeded onto 96-well plates at a density of 10 
| Evaluation of H 2 S release in AsPC-1 cells
The evaluation of H 2 S release into the cytosol of AsPC-1 cells was assessed by the spectrofluorometric method as previously described (Barresi et al., 2017) . Briefly, AsPC-1 cells were cultured up to approximately 90% confluence, and 24 hr before the experiment, cells were seeded onto a 96-well black plate at a density of 72 × 10 3 cells per well.
After 24 hr, the cells were preloaded with a 100 μM solution of the fluorescent dye WSP-1 (Washington State Probe-1, Cayman
Chemical; Liu et al., 2011) . WSP-1 was first incubated with AsPC-1 cells for 30 min (allowing cells to upload the dye), then the supernatant was removed and replaced with a solution of the compounds to be tested, a reference drug or vehicle (dimethyl sulfoxide, DMSO 1%).
The well-known H 2 S-releasing agent diallyl disulfide (DADS; Benavides et al., 2007; Liang, Wu, Wong, & Huang, 2015) was selected as a reference drug because it shows some physiochemical similarities to ERU (relatively low molecular weight, no charge, lipophilicity). The tested compound ERU, at the following concentrations 10, 30, and 100 μM and DADS 100 μM were first dissolved in DMSO and then diluted in buffer standard. This range of concentrations was selected on the basis of the anticancer concentrations found in the literature for several ITCs (Su et al., 2015) . When WSP-1 reacts with H 2 S, it releases a fluorophore detectable by a spectrofluorometer at λ = 465-515 nm (Peng et al., 2014) . The increase in fluorescence (expressed as fluorescence index = FI) was monitored for 45 min using a spectrofluorometer (EnSpire, Perkin Elmer). 2.5 | Analysis of cell cycle, caspase 3/7 activity, mitochondrial potential, and ERK1/2 phosphorylation 2.5.1 | General conditions
| Wound healing assay
AsPC-1 cells were seeded, and after 24 hr, to allow cell attachment, the medium was replaced, and the cells were treated for 72 hr with 30 μM ERU, 10 μM Paclitaxel (positive control for caspase 3/7 activity), or vehicle (DMSO 1%) or were not treated.
| Cell cycle assay
The distribution of the cell cycle was analysed by flow cytometry using the Muse™ Cell Cycle Kit from EMD Millipore Bioscience. Cell cycle analysis was performed according to the manufacturer's protocol.
AsPC-1 cells were seeded into 6-well plates at a density of 5 × 10 5 cells per well, and after incubation with the treatments (see general conditions), the cells were washed with PBS, detached, and fixed with 1 ml ice-cold 70% ethanol at −20°C for at least 3 hr. The cells were then washed with PBS, and 1 × 10 6 cells were stained with 200 μL of muse cell cycle reagent for 30 min at 37°C in the dark. Then, the cells were analysed by the Muse™ Cell Analyzer.
| Caspase 3/7 activity
Caspase 3/7 activity was analysed by flow cytometry using the Muse™ Caspase 3/7 Activity Kit from EMD Millipore Bioscience. 
| Analysis of mitochondrial potential
| Statistical analysis
Experiments were performed in triplicate each in three replicates. All data were expressed as the mean ± standard error; ANOVA (followed by Bonferroni post test, when required) and student's t test were selected for the statistical analysis. p < 0.05 was considered representative of significant differences (software: GraphPad Prism 6.0).
3 | RESULTS
| Production of natural ERU
Natural ERU (0.146 g, 0.878 mmol, 84% yield) was recovered as a lightyellow oil from the myrosinase catalysed hydrolysis of glucoerucin (96% purity, 0.5 g, 1.042 mmol). GC-MS analysis revealed a 97% purity level based on weight of ERU and the presence of 5-(methylsulfanyl)
pentanenitrile at 1.7% based on the total peak area (Figure 1 ).
| Fluorometric recording of intracellular H 2 Srelease
In a previous study, we reported the ability of ERU and other isothiocyanates to release H 2 S in a cell-free amperometric assay . According to these data, ERU exhibited a profile of a slow H 2 S-donor able to increase the release of H 2 S in the presence of an excess of L-cysteine, which was added into the medium (PBS buffer, pH = 7.4) to mimic a biological environment, rich in thiol groups. In the current study, we found that ERU releases H 2 S also inside cells.
In particular, in this experimental assay, the increase of H 2 S-release FIGURE 1 GC chromatogram, MS spectra, and chemical structure of erucin (ERU). GC chromatogram and MS spectra (insert) of natural ERU purified after exogenous myrosinase hydrolysis of glucoerucin from Eruca sativa seeds [Colour figure can be viewed at wileyonlinelibrary.com] inside the AsPC-1 cell line was followed for 45 min until reaching the FI plateau (Figure 2a) . The area under the curve (AUC) graph allows to better appreciate that ERU releases H 2 S in a concentration-dependent manner when administered to AsPC-1 cells at 10, 30, and 100 μM and that the highest concentration induces a H 2 S-release of approximately 40% of that of the natural reference H 2 S-donor DADS at the same concentration (Figure 2b ).
| Cell viability
The results, expressed as a percentage of the value recorded for the vehicle-treated AsPC-1, showed a significant and concentrationdependent reduction of cell viability in cells treated for 72 hr with both 30 and 100 μM of ERU, whereas the 10 μM concentration did not evoke any inhibition. This ERU-induced inhibition of cell viability reached an efficacy value of approximately 90% at the highest concentration administered (100 μM) and a pIC50 value of 4.43 ± 0.01 (Figure 2c ).
| The ERU-induced inhibition of AsPC-1 cell migration
The inhibition of AsPC-1 cell migration induced by two different concentrations of ERU (10 and 30 μM) was assessed by a wound healing assay at 24, 48, and 72 hr. The 10 and 30 μM concentrations of ERU were selected because they showed submaximal effects on cell viability, and this feature made them more suitable for the wound healing assay than the 100 μM, which would cause a massive cell death. In this assay, untreated cells exhibited a time-dependent wound healing rate recorded after 24, 48, and 72 hr (Table 1) . Treatment with vehicle decreased the wound healing rate, but only after 24 hr, while after 48
and 72 hr, a recovery of wound healing rate percentage was observed (Table 1) . Finally, treatment with ERU inhibited the migration of AsPC-1 cells in a concentration-dependent manner, at all timepoints ( Figure 3a) . In fact, wound healing ranges and migration rates were significantly decreased in AsPC-1 cells treated with 30 and 10 μM ERU (Figure 3b ; Table 1 ).
| Inhibition of the cell cycle
After 72 
| Proapoptotic effects of ERU
In this work, we also investigated the ability of ERU to induce mitochondrial depolarization (a marker of early apoptosis). As shown in the graph (Figure 5d ), 72 hr of treatment with 30 μM ERU, induced 13.0% ± 1.0) and apoptotic dead cells (vehicle: 9.6% ± 1.4 vs. 
| ERK1/2 phosphorylation in AsPC-1 cells
The MAPK/ERK pathway represents a fundamental step in cell proliferation, growth, and survival, and, as recently observed for other natural isothiocyanates, the inhibition of ERK phosphorylation represents a key target to suppress cancer cell proliferation (Jeong et al., 2017) . 
| DISCUSSION
Natural isothiocyanates have been known for their anticancer and chemopreventive effects (Jeon, Yoo, Jang, Jang, & Nam, 2011) . Among natural isothiocyanates, the most studied is SFN, which is present in Brassica oleracea L. var. italica (broccoli), in particular, and few other species. ERU is a close analogue of SFN and is the isothiocyanate that is most present in rocket salad species, particularly in E. sativa Mill.
seeds, in which its content is commonly close to 100 μmol/g (Lazzeri,
Errani, Leoni, & Venturi, 2004). In the human body, ERU can also be found as a metabolite derived from the in vivo reduction of SFN (Melchini & Traka, 2010) . Among the several mechanisms of action proposed for the chemopreventive and anticancer properties of isothiocyanates, a recent observation of SFN was very promising: At low concentrations (1-5 μM), SFN was able to promote cell proliferation, whereas at high concentrations (10-40 μM), SFN inhibited cell proliferation, cell migration, and angiogenesis in several cancer types (Bao, Wang, Zhou, & Sun, 2014) . This particular behaviour is called "hormesis," which has also been used to describe the endogenous gasotransmitter hydrogen sulfide (Hellmich et al., 2015) . Recently, our research group demonstrated that isothiocyanates, including natural isothiocyanates derived from Brassicaceae such as ERU, are real H 2 S donors that are able to increase their release of H 2 S in environments rich in free thiol groups such as biological environments (for instance, the cell cytosol; Citi et al., 2014; Martelli et al., 2014) .
Natural isothiocyanates showed anticancer and chemopreventive properties with hormetic behaviour. Our group has already demonstrated that the natural isothiocyanate ERU exhibits hydrogen sulfide-releasing properties, and, because there is an intriguing overlap in the anticancer effect of isothiocyanates and H 2 S, in this work, we evaluated the anticancer properties of the natural isothiocyanate ERU on one of the most aggressive pancreatic adenocarcinoma cell lines (AsPC-1).
The first investigation was aimed at detecting the ability of ERU to release H 2 S inside AsPC-1 cells, thus showing the ability to cross the AsPC-1 cell membrane and release H 2 S at the intracellular level.
As clearly highlighted in the experiments carried out with the fluorometric dye WSP-1, ERU was able to release H 2 S inside cells in a concentration-dependent manner, and this observation led to the conclusion that ERU acts as a H 2 S donor at the intracellular level.
Exogenous H 2 S exhibits antiproliferative effects in different cancer cell lines (Ma et al., 2018) . Consistently, the anticancer effects of slow shows potent anti-hepatocellular carcinoma activity by blocking the STAT3 pathway (Lu, Gao, Huang, & Wang, 2014) . Even other natural H 2 S donors, such as acetyl deacylase disulfide, have been reported to promote H 2 S-mediated anticancer effects (De Cicco et al., 2017) .
On the basis of these premises, we hypothesize that the H 2 S-releasing effects of ERU could be a reasonable mechanism for its anticancer effects. Consistently in this work, 72 hr of incubation with ERU (Deer et al., 2010) . On this basis, we investigated the effect of 72 hr of treatment with 30 μM ERU on the phosphorylation of ERK1/2 in AsPC-1 cells. ERU did not affect the expression of ERK1/2 but led to significantly lower levels of phosphorylated ERK1/2. Because ERK1/2 is involved in the regulation of cell proliferation and cell survival, this ERU-mediated effect may contribute to the anticancer activity of this isothiocyanate.
| CONCLUSIONS
This work delineates the chemopreventive and anticancer profile of ERU in pancreatic adenocarcinoma. Our group first described natural and synthetic isothiocyanates as molecules that are able to release H 2 S. In this study, we demonstrated that treatment with ERU promotes a significant intracellular increase of this gasotransmitter in AsPC-1 cells.
Moreover, high concentrations of ERU (30-100 μM) inhibited AsPC-1 cell viability. ERU also inhibited cell migration and altered the AsPC-1 cell cycle, reducing G0/G1 phase and increasing G2/M and S phases, demonstrating proapoptotic effects in the early and mild stages. Finally, ERU administration was associated with reduced levels of phosphorylated ERK1/2. This feature is particularly important in pancreatic AsPC-1 cells because AsPC-1 are characterized by an activating mutation in KRAS that determines the hyperphosphorylation of ERK1/2 kinase, leading to pancreatic cancer cell proliferation, growth, and survival.
Despite the wide characterization of ERU anticancer activities in human pancreatic adenocarcinoma, this study did not include in vivo experiments on animal xenograft models. This aspect is interesting, has many implications, and will be the main topic of future work. In conclusion, these data highlight the interesting biological properties of ERU, which can pave the way to a potential pharmacological exploitation of this compound and its analogues and facilitate the development of intriguing perspectives for nutraceutical products derived from E. sativa Mill.
